Analysis of physiological functions of target proteins of tetanus and diphtheria toxins using complexes of homologous fragments of the toxins

使用毒素同源片段复合物分析破伤风和白喉毒素靶蛋白的生理功能

基本信息

项目摘要

Tetanus and diphtheria toxins were highly purified by procedures includind HPLC.Two complementary polypeptide fragments from each toxin were separated and highly purified, using a Mono Q column in an FPLC system, from toxins dissociated by reduction with dithiothreitol (DTT) and treatment with 4M-2M urea. Complexes composed of an N-terminal enzymatic, active frament and a C-terminal cell-binding fragment from the different toxins were prepared by using CDI [1-ethyl-3- (3-L-dimethyl aminopropyl) carbodiimide-HCl] or SPDP [N-succinimidyl 3- (2-pyridyldithio) propionate] or by oxidation and removing urea by dialysis from a mixture of the dissociated toxins. Cytotoxicity on Vero and PC12 cells, dermonecrotizing activity and lethal, neurotoxic activities on guinea pigs of the complexes were examined, In contrast to the oridinal toxins and the respectivereconstituted toxins, these complexes composed of an enzymatic active fragment and a cell-binding fragment from different origins elicited only slight toxicity. But the complexes composed of the diphtheria toxin fragment A or diphrheria toxin and a nerve growth factor prepared by using CDI elicited cholinergic neuron-specfic cytotoxicity, indicating that the fragment A in the complex pepeared using CDI retained its enzymatic activity. The mixture of reconstituted complexes from the mixture of DTT-reduced, urea-dissociated toxins appeared to show an increase in cytotoxicity on Vero cells. So the cytotoxicity of the isolated and purified preparations of reconstituted and recombined materials are now being investigaed. The effects of the purified recombined toxins on noradrenaline release from neurosecretoy PC12 cell and lethal, neurotoxic activity of these materials on guinea pigs and diphtheria toxin-resistant rats and mice are being investigated together with the neutralizing effects of antibodies against each toxin-fragment.
采用高效液相色谱等方法对破伤风和白喉毒素进行了高度纯化。通过双硫苏糖醇(DTT)还原和4M-2M尿素处理,从每种毒素中分离出两个互补的多肽片段,并使用FPLC系统中的Mono Q柱进行高度纯化。用CDI[1-乙基-3- (3- l-二甲基氨基丙基)碳二酰亚胺- hcl]或SPDP [n -琥珀酰亚基3-(2-吡啶二硫)丙酸盐]或从解离毒素混合物中氧化和透析去除尿素,制备了由不同毒素组成的n端酶促、活性片段和c端细胞结合片段组成的配合物。研究了复合物对Vero和PC12细胞的细胞毒性、皮肤坏死活性以及对豚鼠的致死性神经毒性。与原始毒素及其各自构成的毒素相比,这些复合物由不同来源的酶活性片段和细胞结合片段组成,仅引起轻微的毒性。但用CDI制备的白喉毒素片段A或白喉毒素与神经生长因子组成的复合物可引起胆碱能神经元特异性细胞毒性,说明用CDI制备的复合物中的片段A保留了其酶活性。从dtt还原的尿素解离毒素混合物中重组复合物的混合物似乎显示出对Vero细胞的细胞毒性增加。因此,目前正在研究重组和重组材料的分离和纯化制剂的细胞毒性。纯化的重组毒素对神经分泌腺PC12细胞释放去甲肾上腺素的影响,以及这些物质对豚鼠和白喉毒素抗性大鼠和小鼠的致死性神经毒性活性,以及针对每种毒素片段的抗体的中和作用,正在进行研究。

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Matsuda: "Bacrerial exotoxins and their mechanisms of actions : 4) Tetanus toxin [in Japanese]" Treatment. 13. 21-27 (1997)
M.Matsuda:“细菌外毒素及其作用机制:4)破伤风毒素[日语]”治疗。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
松田守弘: "破傷風" 化学療法の領域. 12. 598-605 (1996)
松田守宏:“破伤风”化疗领域。12. 598-605 (1996)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
松田 守弘: "破傷風毒素(テタヌストキシン)" 神経精神薬理. 19・4. 221-232 (1997)
松田护弘:“破伤风毒素”神经精神药理学19・4(1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
松田 守弘: "細菌外毒素とその作用機序4)破傷風毒素" 治療学. 31・12. 21-27 (1997)
松田守弘:“细菌外毒素及其作用机制4)破伤风毒素”治疗学31・12(1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Matsuda et al.: Improved vaccines and treatments of tetanus on the basis of the structure and function of the tetanus toxin molecule, to reduce tetanus deaths to zero.Biomedical Aspects of Clostridial Neurotoxins Plenum Press (in press), (1998)
M.Matsuda 等人:根据破伤风毒素分子的结构和功能改进破伤风疫苗和治疗方法,将破伤风死亡人数降至零。梭状芽胞杆菌神经毒素的生物医学方面 Plenum Press(印刷中),(1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUDA Morihiro其他文献

MATSUDA Morihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUDA Morihiro', 18)}}的其他基金

Ebaluation of the efficacy of single chain recombinant antibody fragments derived from an anti-tetanus human monoclonal antibody with high toxin-neutralizing activity as a model
以具有高毒素中和活性的抗破伤风人单克隆抗体衍生的单链重组抗体片段作为模型的功效评价
  • 批准号:
    14570249
  • 财政年份:
    2002
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the application of anti-tetanus human monoclonal antibodies having high neutralizing activity to use in place of current polyclonal tetanus antitoxin preparations.
应用具有高中和活性的抗破伤风人单克隆抗体代替现有多克隆破伤风抗毒素制剂的研究。
  • 批准号:
    07557212
  • 财政年份:
    1995
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analyses, using toxin fragment, of disturbances in autonomic nervous system in tetanus intoxication, a possible major cause of tetanus death
使用毒素片段分析破伤风中毒中自主神经系统的紊乱,这是破伤风死亡的可能主要原因
  • 批准号:
    60480164
  • 财政年份:
    1985
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Enhancing drug delivery with diphtheria toxin-coated colloidal drug aggregates
用白喉毒素包被的胶体药物聚集体增强药物输送
  • 批准号:
    553239-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Modelling the interactome of Diphtheria Toxin with the promiscuous biotinylating enzyme TurboID
使用混杂生物素化酶 TurboID 对白喉毒素的相互作用组进行建模
  • 批准号:
    449373
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Studentship Programs
Engineering a Deimmunized Diphtheria Toxin Platform for Drug Delivery
设计用于药物输送的去免疫白喉毒素平台
  • 批准号:
    529234-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Drug Derivery to Cancer Cells Utilizing Active Trasport of Diphtheria Toxin Protein
利用白喉毒素蛋白的主动运输将药物输送至癌细胞
  • 批准号:
    17K14520
  • 财政年份:
    2017
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Adjuvant Discovery For Diphtheria Toxin Vaccine
白喉毒素疫苗佐剂的发现
  • 批准号:
    8936750
  • 财政年份:
    2014
  • 资助金额:
    $ 4.22万
  • 项目类别:
Identification of host cell factors involved in diphtheria toxin sensitivity by using shRNA library.
利用shRNA文库鉴定参与白喉毒素敏感性的宿主细胞因子。
  • 批准号:
    20390127
  • 财政年份:
    2008
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Generation of a transgenic mouse that expressing human diphtheria toxin receptor cDNA under the control of the transcription regulatory regions of ghrelin
产生在生长素释放肽转录调控区控制下表达人白喉毒素受体 cDNA 的转基因小鼠
  • 批准号:
    19790648
  • 财政年份:
    2007
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Modified Diphtheria Toxin IL-7 Fusion Toxins
改良白喉毒素 IL-7 融合毒素
  • 批准号:
    7110847
  • 财政年份:
    2006
  • 资助金额:
    $ 4.22万
  • 项目类别:
Transition State Analysis of Diphtheria Toxin
白喉毒素的过渡态分析
  • 批准号:
    6445726
  • 财政年份:
    2002
  • 资助金额:
    $ 4.22万
  • 项目类别:
SYNCHROTRON--SUPEROXIDE DISMUTASE, DIPHTHERIA TOXIN, DE NOVO DESIGNED PEPTIDES
SYNCHROTRON--超氧化物歧化酶、白喉毒素、从头设计的肽
  • 批准号:
    6658575
  • 财政年份:
    2002
  • 资助金额:
    $ 4.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了